BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27002954)

  • 1. Recurrence in patients with clinically early-stage papillary thyroid carcinoma according to tumor size and surgical extent.
    Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Am J Surg; 2016 Sep; 212(3):419-425.e1. PubMed ID: 27002954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.
    Conzo G; Mauriello C; Docimo G; Gambardella C; Thomas G; Cavallo F; Tartaglia E; Napolitano S; Varriale R; Rossetti G; Fei L; Santini L
    Int J Surg; 2014; 12 Suppl 1():S194-7. PubMed ID: 24862675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases.
    Bozec A; Dassonville O; Chamorey E; Poissonnet G; Sudaka A; Peyrottes I; Ettore F; Haudebourg J; Bussière F; Benisvy D; Marcy PY; Sadoul JL; Hofman P; Lassale S; Vallicioni J; Demard F; Santini J
    Eur Arch Otorhinolaryngol; 2011 Aug; 268(8):1205-1212. PubMed ID: 21607578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
    Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
    Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection.
    Nixon IJ; Wang LY; Ganly I; Patel SG; Morris LG; Migliacci JC; Tuttle RM; Shah JP; Shaha AR
    Br J Surg; 2016 Feb; 103(3):218-25. PubMed ID: 26511531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
    Ryu YJ; Cho JS; Park MH; Yoon JH
    BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical extent of central lymph node dissection in clinically node-negative papillary thyroid cancer.
    Kim WW; Park HY; Jung JH
    Head Neck; 2013 Nov; 35(11):1616-20. PubMed ID: 23322499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral neck recurrence from papillary thyroid carcinoma: Predictive factors and prognostic significance.
    Giordano D; Frasoldati A; Kasperbauer JL; Gabrielli E; Pernice C; Zini M; Pedroni C; Cavuto S; Barbieri V
    Laryngoscope; 2015 Sep; 125(9):2226-31. PubMed ID: 25510637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level I lymph node involvement in patients with N1b papillary thyroid carcinoma: a prospective study.
    Eweida AM; Sakr MF; Hamza Y; Khalil MR; Gabr E; Koraitim T; Al-Wagih HF; Abo-Elwafa W; Ezzat Abdel-Aziz T; Diab AA; El-Sabaa B; Nabawi AS
    Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1951-1958. PubMed ID: 27999997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation Between Surgical Extent and Prognosis in Node-Negative, Early-Stage Papillary Thyroid Carcinoma Originating in the Isthmus.
    Lim ST; Jeon YW; Suh YJ
    World J Surg; 2016 Feb; 40(2):344-9. PubMed ID: 26446448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lateral lymph node recurrence after total thyroidectomy and central neck dissection in patients with papillary thyroid cancer without clinical evidence of lateral neck metastasis.
    Lim YC; Liu L; Chang JW; Koo BS
    Oral Oncol; 2016 Nov; 62():109-113. PubMed ID: 27865362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: Comparison of unilateral versus bilateral central neck dissection.
    Yoo HS; Shin MC; Ji YB; Song CM; Lee SH; Tae K
    Asian J Surg; 2018 Jul; 41(4):363-369. PubMed ID: 28454667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Ultrasound Characteristics With Extranodal Extension in Metastatic Papillary Thyroid Carcinoma.
    Qualliotine JR; Coquia SF; Hamper UM; Fakhry C
    JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):263-9. PubMed ID: 26846933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma.
    Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
    Surgery; 2015 Dec; 158(6):1500-11. PubMed ID: 26120069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
    Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
    Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.